REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/21/2025
Back to search
Official data from USPTO
CAELUM BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CAELUM BIOSCIENCES
ST13
US500000087982774Class
42
Filing
87982774
Registration
6037766
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
04/22/2025
Trademark type
Word
Nice classes
42
Filing date
01/12/2017
Registration date
04/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2020
Last transaction
04/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2017
First use in commerce
01/01/2017
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
GALBO, AMANDA
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Caelum Biosciences, Inc.
Representatives
Cara M. Kearney AstraZeneca Pharmaceuticals LP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biochemical research and development; Biological research; Biotechnology research; Chemicalbiochemicalbiological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesitydiabetesincontinencecardiovascular diseasescentral nervous system diseases and disordersmetabolic disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasessolid organ transplant rejectionprogressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical purposes in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research for medical purposes in the field of obesitydiabetesincontinencecardiovascular diseasescentral nervous system diseases and disordersmetabolic disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasessolid organ transplant rejectionprogressive organ disease and failure; Scientific research for medical purposes in the field of serious and life threatening diseases; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals; Research services in the field of proteinsantibodiesmicroorganisms and cells; Research and development services in the field of antibody technology; Structural and functional analysis of genomes; DNA screening for scientific research purposes; Biochemical research and analysis; research and development services in the field of immunology
Publications
History of USPTO decisions and trademark events.
51 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/26/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/26/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/26/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/17/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/15/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/26/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
02/26/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/26/2020
IUAF
USE AMENDMENT FILED
01/27/2020
DRRR
DIVISIONAL REQUEST RECEIVED
01/27/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/27/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/27/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/27/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/27/2019
EX3G
SOU EXTENSION 3 GRANTED
06/25/2019
EXT3
SOU EXTENSION 3 FILED
06/25/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/25/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2019
EX2G
SOU EXTENSION 2 GRANTED
01/07/2019
EXT2
SOU EXTENSION 2 FILED
01/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/21/2018
EX1G
SOU EXTENSION 1 GRANTED
07/19/2018
EXT1
SOU EXTENSION 1 FILED
07/19/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/19/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2017
PUBO
PUBLISHED FOR OPPOSITION
12/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2017
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
04/28/2017
ALIE
ASSIGNED TO LIE
04/28/2017
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/28/2017
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/28/2017
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
04/28/2017
DOCK
ASSIGNED TO EXAMINER
04/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2017
NWAP
NEW APPLICATION ENTERED
01/16/2017
Continuous trademark protection
Get notified about every new filing that threatens CAELUM BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.